logo-loader
viewIntegumen

Integumen PLC - Director/PDMR Shareholdings

RNS Number : 9607W
Integumen PLC
16 December 2019
 

16 December 2019

 

Integumen PLC

 

("Integumen" or "Company")

 

Director/PDMR Shareholdings

 

 

Further to the announcement released by the Company on 9 December 2019, and following admission of 91,253,530 new Ordinary Shares to trading on AIM ("Admission") this morning, Integumen announces the following PDMR Shareholdings arising as a result of the Ordinary Shares issued and allotted pursuant to the Subscription.

 

The following table sets out details of the Directors' share dealings and resulting interests in the Company's issued share capital:

 

Director

Shares subscribed for on 9 December 2019

Resulting interest

Resulting interest (%)

Gerard Brandon

1,084,511

50,199,012

4.68%

Camillus Glover

1,084,510

42,506,704

3.96%

Fionán Murray

1,084,510

87,867,578

8.19%

 

Total Voting Rights

 

Following Admission, the Company's issued share capital consists of 1,072,416,903 ordinary shares of 0.01 pence each.

 

The above figure of 1,072,416,903 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Market Abuse Regulation (MAR) Disclosure

 

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

Capitalised terms used in this announcement shall have the same meaning as in the announcement released by the Company on 9 December 2019.

 

Enquiries:

 

Integumen plc

Gerard Brandon, CEO

+44 (0) 7340 055 648




SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin

+44 (0) 113 370 8974




Turner Pope Investments (TPI) Limited

(Broker)

Andy Thacker/Zoe Alexander

+44 (0) 20 3657 0050

 

 

About Integumen: www.integumen.com

Integumen is a vertically integrated product and services company for skin related diseases, treatments and therapies with four business units: 

 

·      Labskin AI's technology platform incorporates artificial intelligence within clinical research for medical device, pharmaceuticals, cosmeceuticals and related life science test services.  Labskin allows skincare, healthcare, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.

·      Rinodrive is a data aggregation, refining and AI analysis open-source eco-system designed to provide third-party service providers the ability to offer their clients valuable insights that support clinical, operational and financial decisions in healthcare services, third-level education, government departments and the financial sector.

·      Wound pHase is developing skin and wound care products using its proprietary wound dressing technology. Working in collaboration with CBD providers creating a CBD infused diabetic wound care product range.

·      Stoer-for-men skin products e-commerce division offers a range of skincare products derived from 5 natural super-ingredient plant extracts specifically for men to reduce the signs of ageing and is also used as a control for client testing within Labskin laboratories.

 

 

 

 

FORM FOR NOTIFYING DEALINGS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Gerard Brandon

2

Reason for the notification

a)

Position/status

Chief Executive Officer (PDMR)

b)

Initial notification/ Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Integumen PLC

b)

LEI

213800M477RQVVHVUD72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 0.01 pence each

Identification code GB00BYWJ6269

 

b)

Nature of the transaction

Acquisition of ordinary shares (subscription)

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1.5 pence

1,084,511

d)

Aggregated information - Aggregated volume and Price

Price(s)

Volume(s)

1.5 pence

1,084,511

 

Total - £16,267.67

e)

Date of the transaction

16 December 2019

f)

Place of the transaction

X.LON

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Camillus Glover

 

2

Reason for the notification

a)

Position/status

Chief of Finance and Operations (PDMR)

b)

Initial notification/ Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Integumen PLC

b)

LEI

213800M477RQVVHVUD72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 0.01 pence each

Identification code GB00BYWJ6269

 

b)

Nature of the transaction

Acquisition of ordinary shares (subscription)

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1.5 pence

1,084,510

d)

Aggregated information - Aggregated volume and Price

Price(s)

Volume(s)

1.5 pence

1,084,510

 

Total - £16,267.65

e)

Date of the transaction

16 December 2019

f)

Place of the transaction

X.LON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Fionán Murray

2

Reason for the notification

a)

Position/status

Group Sales Director (PDMR)

b)

Initial notification/ Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Integumen PLC

b)

LEI

213800M477RQVVHVUD72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 0.01 pence each

Identification code GB00BYWJ6269

 

b)

Nature of the transaction

Acquisition of ordinary shares (subscription)

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1.5 pence

1,084,510

d)

Aggregated information - Aggregated volume and Price

Price(s)

Volume(s)

1.5 pence

1,084,510

 

Total - £16,267.65

e)

Date of the transaction

16 December 2019

f)

Place of the transaction

X.LON

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHTFBPTMBJBMLL

Quick facts: Integumen

Price: 1.33

Market: AIM
Market Cap: £14.26 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Integumen's Gerry Brandon discusses launch of new AI bacteria monitoring system

Integumen PLC's (LON:SKIN) Gerry Brandon speaks to Proactive London's Andrew Scott soon after announcing the launch of a new green-tech real-time system that monitors water for bacteria contamination using artificial intelligence. The formal unveiling of ecowaterOS, which is being developed...

15 hours, 53 minutes ago